|
1
|
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications.
|
Blood
|
2011
|
1.76
|
|
2
|
Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants.
|
Blood
|
2010
|
1.32
|
|
3
|
Establishment of BCWM.1 cell line for Waldenström's macroglobulinemia with productive in vivo engraftment in SCID-hu mice.
|
Exp Hematol
|
2007
|
1.26
|
|
4
|
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.
|
Mol Cancer Ther
|
2008
|
1.23
|
|
5
|
Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
|
J Clin Oncol
|
2008
|
1.15
|
|
6
|
A combined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells.
|
J Microbiol Methods
|
2004
|
1.13
|
|
7
|
RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma.
|
Blood
|
2004
|
1.07
|
|
8
|
Microfluidic chips for detecting the t(4;14) translocation and monitoring disease during treatment using reverse transcriptase-polymerase chain reaction analysis of IgH-MMSET hybrid transcripts.
|
J Mol Diagn
|
2007
|
0.85
|
|
9
|
Discovery and characterization of novel mutant FLT3 kinase inhibitors.
|
Mol Cancer Ther
|
2010
|
0.84
|
|
10
|
Reversible resistance induced by FLT3 inhibition: a novel resistance mechanism in mutant FLT3-expressing cells.
|
PLoS One
|
2011
|
0.84
|
|
11
|
Novel agents in the treatment of Waldenström's macroglobulinemia.
|
Clin Lymphoma Myeloma
|
2007
|
0.83
|
|
12
|
An adaptable microvalving system for on-chip polymerase chain reactions.
|
J Immunol Methods
|
2005
|
0.83
|
|
13
|
Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom Macroglobulinemia.
|
Br J Haematol
|
2009
|
0.81
|
|
14
|
The dChip survival analysis module for microarray data.
|
BMC Bioinformatics
|
2011
|
0.80
|
|
15
|
Sensitive detection using microfluidics technology of single cell PCR products from high and low abundance IgH VDJ templates in multiple myeloma.
|
J Immunol Methods
|
2005
|
0.77
|
|
16
|
Retracted
MicroRNAs 15a/16-1 function as tumor suppressor genes in multiple myeloma.
|
Blood
|
2010
|
0.75
|